Emcure Pharmaceuticals reports 41% surge in Q1 net profit driven by strong domestic and international growth

Pune-based Emcure Pharmaceuticals on Thursday reported a 41% year-on-year increase in first quarter net profit at Rs 215 crore. Revenue from operations rose 16% to Rs 2,101 crore, driven by robust performance in domestic and international businesses. The company’s EBITDA margins for April-June stood at 19.2% with EBITDA up 20.1% YoY.